These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26219658)

  • 1. A comparison of discrimination learning in touchscreen and 2-choice swim tank using an allelic series of Huntington's disease mice.
    Glynn D; Skillings EA; Morton AJ
    J Neurosci Methods; 2016 May; 265():56-71. PubMed ID: 26219658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive deficits in transgenic and knock-in HTT mice parallel those in Huntington's disease.
    Farrar AM; Murphy CA; Paterson NE; Oakeshott S; He D; Alosio W; McConnell K; Menalled LB; Ramboz S; Park LC; Howland D; Brunner D
    J Huntingtons Dis; 2014; 3(2):145-58. PubMed ID: 25062858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation.
    Lione LA; Carter RJ; Hunt MJ; Bates GP; Morton AJ; Dunnett SB
    J Neurosci; 1999 Dec; 19(23):10428-37. PubMed ID: 10575040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed Onset and Reduced Cognitive Deficits through Pre-Conditioning with 3-Nitropropionic Acid is Dependent on Sex and CAG Repeat Length in the R6/2 Mouse Model of Huntington's Disease.
    Skillings EA; Morton AJ
    J Huntingtons Dis; 2016; 5(1):19-32. PubMed ID: 27031731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington's disease mice.
    Suelves N; Kirkham-McCarthy L; Lahue RS; Ginés S
    Sci Rep; 2017 Jul; 7(1):6082. PubMed ID: 28729730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mobile, high-throughput semi-automated system for testing cognition in large non-primate animal models of Huntington disease.
    McBride SD; Perentos N; Morton AJ
    J Neurosci Methods; 2016 May; 265():25-33. PubMed ID: 26327320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive decline in Huntington's disease expansion gene carriers.
    Baake V; Reijntjes RHAM; Dumas EM; Thompson JC; ; Roos RAC
    Cortex; 2017 Oct; 95():51-62. PubMed ID: 28843844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
    J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive imbalance in the interaction between spatial and procedural memory systems in the R6/2 mouse model of Huntington's disease.
    Ciamei A; Morton AJ
    Neurobiol Learn Mem; 2009 Oct; 92(3):417-28. PubMed ID: 19524696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers.
    Hahn-Barma V; Deweer B; Dürr A; Dodé C; Feingold J; Pillon B; Agid Y; Brice A; Dubois B
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):172-7. PubMed ID: 9489526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utilisation of operant delayed matching and non-matching to position for probing cognitive flexibility and working memory in mouse models of Huntington's disease.
    Yhnell E; Dunnett SB; Brooks SP
    J Neurosci Methods; 2016 May; 265():72-80. PubMed ID: 26321735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early deficits in declarative and procedural memory dependent behavioral function in a transgenic rat model of Huntington's disease.
    Kirch RD; Meyer PT; Geisler S; Braun F; Gehrig S; Langen KJ; von Hörsten S; Nikkhah G; Cassel JC; Döbrössy MD
    Behav Brain Res; 2013 Feb; 239():15-26. PubMed ID: 23137697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease.
    Zappacosta B; Monza D; Meoni C; Austoni L; Soliveri P; Gellera C; Alberti R; Mantero M; Penati G; Caraceni T; Girotti F
    Arch Neurol; 1996 Jun; 53(6):493-7. PubMed ID: 8660149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-environment interactions modulating cognitive function and molecular correlates of synaptic plasticity in Huntington's disease transgenic mice.
    Nithianantharajah J; Barkus C; Murphy M; Hannan AJ
    Neurobiol Dis; 2008 Mar; 29(3):490-504. PubMed ID: 18165017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene.
    Ishiguro H; Yamada K; Sawada H; Nishii K; Ichino N; Sawada M; Kurosawa Y; Matsushita N; Kobayashi K; Goto J; Hashida H; Masuda N; Kanazawa I; Nagatsu T
    J Neurosci Res; 2001 Aug; 65(4):289-97. PubMed ID: 11494364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early cognitive dysfunction in the HD 51 CAG transgenic rat model of Huntington's disease.
    Fink KD; Rossignol J; Crane AT; Davis KK; Bavar AM; Dekorver NW; Lowrance SA; Reilly MP; Sandstrom MI; von Hörsten S; Lescaudron L; Dunbar GL
    Behav Neurosci; 2012 Jun; 126(3):479-87. PubMed ID: 22642889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of behavioural despair in R6/2 and Hdh knock-in mouse models recapitulates depression in Huntington's disease.
    Ciamei A; Detloff PJ; Morton AJ
    Behav Brain Res; 2015 Sep; 291():140-146. PubMed ID: 25986402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prefrontal executive function associated coupling relates to Huntington's disease stage.
    Unschuld PG; Liu X; Shanahan M; Margolis RL; Bassett SS; Brandt J; Schretlen DJ; Redgrave GW; Hua J; Hock C; Reading SA; van Zijl PC; Pekar JJ; Ross CA
    Cortex; 2013; 49(10):2661-73. PubMed ID: 23906595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease.
    Nithianantharajah J; Hannan AJ
    Neuroscience; 2013 Oct; 251():66-74. PubMed ID: 22633949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.